← Back to Search

Proton Beam Therapy

Proton Beam Radiation Therapy for Prostate Cancer

N/A
Waitlist Available
Research Sponsored by Abramson Cancer Center at Penn Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Histologically confirmed prostate adenocarcinoma within 365 days of registration
Clinical stages T1a-T2a N0 M0
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial is studying proton radiation therapy to see if it is more effective than standard radiation therapy in treating prostate cancer while causing less damage to normal tissue.

Eligible Conditions
  • Prostate Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute toxicity as assessed by NCI CTC Version 3.0
As a feasibility precaution patients will be treated and followed for a minimum of 60 days after completion of radiotherapy to determine feasibility
Secondary outcome measures
Biochemical/clinical progression-free survival
Late toxicity as assessed by RTOG/EORTC late morbidity scoring system

Trial Design

1Treatment groups
Experimental Treatment
Group I: Arm IExperimental Treatment3 Interventions
Patients undergo proton radiotherapy once daily 5 days a week for approximately 9 weeks in the absence of disease progression or unacceptable toxicity.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Proton Beam Radiation Therapy
2013
Completed Phase 2
~110

Find a Location

Who is running the clinical trial?

Abramson Cancer Center at Penn MedicineLead Sponsor
387 Previous Clinical Trials
145,395 Total Patients Enrolled
12 Trials studying Prostate Cancer
1,017 Patients Enrolled for Prostate Cancer
Abramson Cancer Center of the University of PennsylvaniaLead Sponsor
359 Previous Clinical Trials
104,795 Total Patients Enrolled
12 Trials studying Prostate Cancer
1,017 Patients Enrolled for Prostate Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Proton Radiation Therapy in Treating Patients With Prostate Cancer
2009. "Proton Radiation Therapy in Treating Patients With Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01045226.
~19 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top